|Titre :||HIV, HCV, TB and harm reduction in prisons. Human rights, minimum standards and monitoring at the European and international levels|
|Auteurs :||G. SANDER|
|Type de document :||Rapport|
|Editeur :||London : HRI (Harm Reduction International), 2016|
|Format :||44 p.|
|Discipline :||MAL (Maladies infectieuses / Infectious diseases)|
Thésaurus TOXIBASEPRISON ; DROITS DE L'HOMME ; REDUCTION DES RISQUES ; VIH ; HEPATITE ; TUBERCULOSE ; PRISE EN CHARGE ; TRAITEMENT DE MAINTENANCE ; ECHANGE DE SERINGUES ; QUALITE
Even though prisoners do not forfeit their human rights, such as the right to health, there is an enormous gap between health and human rights standards and their effective implementation in places of detention.
This is in no small part due to the severe lack of harm reduction services for those in detention globally: only seven countries now have a needle and syringe programme, and only 44 provide opioid substitution therapy, in at least one prison.
This is according to this report which identifies some of the most important human rights and public health standards relating to HIV, HCV and TB in prisons, and the vital role of harm reduction provision in ensuring them.
The report recognises that the right to health and freedom from ill treatment are inseparable, which places human rights-based prison monitors, particularly those with a preventative mandate, in a unique and critical position to consider these issues. It notes, however, that this is not yet occurring in an adequately systematic or comprehensive manner, and provides specific recommendations to the European Committee for the Prevention of Torture and Inhuman or Degrading Treatment or Punishment (CPT) and the United Nations Subcommittee on the Prevention of Torture and other Cruel, Inhuman or Degrading Treatment or Punishment (SPT).
|Domaine :||Drogues illicites / Illicit drugs|